Sifat Jubaira/LinkedIn
Feb 15, 2026, 10:26
Sifat Jubaira: K₂-EDTA vs K₃-EDTA – Same Anticoagulant, Very Different Accuracy
Sifat Jubaira, Lab Medicine Specialist at United Hospital Limited, shared a post on LinkedIn:
“K₂-EDTA vs K₃-EDTA – Same Anticoagulant, Very Different Accuracy
Both K₂-EDTA and K₃-EDTA prevent blood clotting by binding calcium.
But their impact on hematology results is not the same.
K₂-EDTA (Dipotassium EDTA)
- Dry, spray-coated
- No dilution effect
- Preserves RBC size and platelet count
- Gold standard for CBC
K₃-EDTA (Tripotassium EDTA)
- Liquid leads to sample dilution
- May falsely decrease Hb, Hct, MCV and platelets
- Alters cell morphology
- No longer recommended for routine hematology
Bottom line:
For accurate hematological values and reliable cell morphology, K₂-EDTA is the anticoagulant of choice.
Authentic References
- ICSH Guidelines – Recommendations for EDTA anticoagulants in hematology
- CLSI GP34 / H21 – Collection, transport and processing of blood specimens
- Bain BJ. Blood Cells: A Practical Guide, Wiley-Blackwell
- Dacie and Lewis. Practical Haematology, Elsevier”
Find more posts featuring Sifat Jubaira on Hemostasis Today.
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:23Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants